MT Group is a boutique CRO specializing in biospecimen sample acquisition and management. The company's slogan "A CRO for biospecimen sample acquisition and management" emphasizes their core focus. MT Group has a track record of over 20 years, during which it has successfully completed hundreds of studies for biopharma clients, involving 10,000+ patients across various disease spaces. Their commitment to providing pristine and customizable samples sets them apart in the field. Since their founding in 2003, MT Group has been a key player in the Biotechnology, Health Care, and Pharmaceutical industries. As of now, there is no public record of their headquarters or their last investment details and investors. MT Group's focus on providing high-quality biospecimen samples and their extensive experience in the field position them as an attractive prospect for potential investors in the healthcare and biotechnology sectors.
There is no investment information
No recent news or press coverage available for MT Group.